discovered that METTL3 catalytically elevates m6A modification levels in the 3’ UTR of SOCS6 mRNA, consequently inhibiting SOCS6 gene expression and blocking ferroptosis, which ultimately contributes to radioresistance in ESCC (58). The gene discussed is SOCS6; the disease is esophageal squamous cell carcinoma.